0.4326  -0.017 (-3.8%)		08-24 16:00
Open: 0.44 High: 0.4599 Volume: 353,384		Pre. Close: 0.4497 Low: 0.4211 Market Cap: 18(M)

Short term
Mid term
Targets	6-month :	0.56	1-year :	0.65
Resists	First :	0.48	Second :	0.56
Pivot price	0.43
Supports	First :	0.39	Second :	0.34
MAs	MA(5) :	0.45	MA(20) :	0.41
	MA(100) :	0.38	MA(250) :	0.53
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	74.7	D(3) :	83.7
RSI	RSI(14): 53.6
52-week	High :	2.59	Low :	0.23

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ SCNX ] has closed below upper band by 49.1%. Bollinger Bands are 37.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.46 - 0.46	0.46 - 0.47
Low:	0.41 - 0.42	0.42 - 0.42
Close:	0.43 - 0.43	0.43 - 0.44

As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.

Sun, 23 Aug 2026
SCNX | Scienture Holdings, Inc. Common Financials - Revenue Breakdown - Quiver Quantitative

Sun, 23 Aug 2026
Scienture stock jumps 21% on REZENOPY commercial launch - scanx.trade

Thu, 20 Aug 2026
Scienture (SCNX) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day; Post-Report: Shares Fall 0.49% in the Latest Session - Earnings Growth Forecast - vinanet.vn

Fri, 14 Aug 2026
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative

Thu, 13 Aug 2026
Scienture Holdings: Q2 Earnings Snapshot - KVUE

Thu, 13 Aug 2026
Scienture Holdings (SCNX) grows ARBLI revenue but remains loss-making in Q2 2026 - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	0 (M)
Shares Float	41 (M)
Held by Insiders	3.279e+007 (%)
Held by Institutions	13.3 (%)
Shares Short	1,170 (K)
Shares Short P.Month	0 (K)

EPS	-1.527e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-6 %
Return on Assets (ttm)	230.8 %
Return on Equity (ttm)	-10.9 %
Qtrly Rev. Growth	477680 %
Gross Profit (p.s.)	113.4
Sales Per Share	-14.29
EBITDA (p.s.)	97136.4
Qtrly Earnings Growth	-2.5 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-13 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.04
Price to Cash Flow	1.04

Dividend	0
Forward Dividend	2.6e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.